Organization: Health Canada
Year: 2023
Month: November
Request Number: A-2023-000754
Request Summary: Adverse Drug Reactions (ADRs) for LISDEXAMFETAMINE DIMESYLATE. Report numbers: E2B_06455930, E2B_06455955, E2B_06455965. ADRs for C1 ESTERASE INHIBITOR (HUMAN). Report numbers: E2B_06405702, E2B_06443436. ADRs for GAMMAGARD LIQUID. Report numbers: 001044600, 001044614, 001044061.
Disposition: Disclosed in part
Number of pages: 81